Nephrotoxicity of a single dose of cyclophosphamide and ifosfamide in rats

2017
journal article
article
dc.abstract.enOxazaphosphorines (cyclophosphamide ñ CP, ifosfamide ñ IF) are alkylating cytostatics used in chemotherapy of cancer and autoimmune diseases. They have numerous adverse effects, including uro- and nephrotoxic, dependent of the type of drug, time of therapy and presence of any coexistent nephrotoxic factors in a treated patient. Purpose of this study was to estimate the renal function and the level of urinary bladder dysfunction occurring in rats following administration of a single, large CP/IF dose. The experiment involved 30 rats who were administered a single intraperitoneal dose of 150 mg/kg b.w. of CP (group 1) or IF (group 2) or normal saline (group 3 ñ control), respectively. Following the administration animals were placed in individual metabolic cages. 24 h later rats were sacrificed, blood collected and nephrectomy and cystectomy performed in order to prepare specimens for histopathological analysis. Circadian diuresis was also assessed, along with a qualitative urine assessment with strip tests and laboratory renal function parameters in plasma and urine: sodium, urea, creatinine and uric acid levels, and circadian elimination of sodium, potassium, urea, creatinine, uric acid and protein. Creatinine clearance, urea clearance and fractionated sodium elimination (FENa) and renal failure index (RFI) were also calculated. An increased diuresis and acidification of urine with reduced circadian elimination of potassium and a significant proteinuria, as well as increased plasma levels of creatinine and urea were found in the group of rats that received a single dose of CP, compared to control animals. Rats treated with IF also demonstrated acidification of urine, reduced circadian potassium elimination, a significant proteinuria and increased plasma creatinine and urea levels, but their diuresis was comparable to that observed in control animals. IF-treated animals were also characterized by reduced urea clearance, FENa and RFI. Histopathological analysis confirmed presence of inflammatory changes in urinary bladders in both groups 1 and 2, and absence of any significant morphological disorders in kidneys. Obtained results suggest a dysfunction of distal tubules and collective tubules developing as a result of administration of a single nephrotoxic dose of IF/CP. FENa and RFI results indicate also a higher nephrotoxic potential of IF administered as a single dose.pl
dc.affiliationWydział Lekarski : Zakład Patofizjologiipl
dc.cm.date2020-01-07
dc.cm.id85184
dc.contributor.authorDobrek, Łukasz - 129181 pl
dc.contributor.authorSkowron, Beata - 161581 pl
dc.contributor.authorBaranowska, Agnieszka - 214008 pl
dc.contributor.authorCiesielczyk, Katarzyna - 162216 pl
dc.contributor.authorKopańska, Martapl
dc.contributor.authorThor, Piotr - 133660 pl
dc.date.accession2019-05-29pl
dc.date.accessioned2020-01-17T09:17:57Z
dc.date.available2020-01-17T09:17:57Z
dc.date.issued2017pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.additionalBibliogr. s. 1589pl
dc.description.number5pl
dc.description.physical1579-1589pl
dc.description.points15pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume74pl
dc.identifier.eissn2353-5288pl
dc.identifier.issn0001-6837pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/141466
dc.identifier.weblinkhttp://ptfarm.pl/en/wydawnictwa/czasopisma/acta-poloniae-pharmaceutica/110/-/27067pl
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa - Użycie niekomercyjne 4.0 Międzynarodowa*
dc.rights.licenceCC-BY-NC
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/legalcode.pl*
dc.share.typeotwarte czasopismo
dc.subject.encyclophosphamidepl
dc.subject.enifosfamidepl
dc.subject.ennephrotoxicitypl
dc.subject.enratspl
dc.subtypeArticlepl
dc.titleNephrotoxicity of a single dose of cyclophosphamide and ifosfamide in ratspl
dc.title.journalActa Poloniae Pharmaceutica. Drug Researchpl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.abstract.enpl
Oxazaphosphorines (cyclophosphamide ñ CP, ifosfamide ñ IF) are alkylating cytostatics used in chemotherapy of cancer and autoimmune diseases. They have numerous adverse effects, including uro- and nephrotoxic, dependent of the type of drug, time of therapy and presence of any coexistent nephrotoxic factors in a treated patient. Purpose of this study was to estimate the renal function and the level of urinary bladder dysfunction occurring in rats following administration of a single, large CP/IF dose. The experiment involved 30 rats who were administered a single intraperitoneal dose of 150 mg/kg b.w. of CP (group 1) or IF (group 2) or normal saline (group 3 ñ control), respectively. Following the administration animals were placed in individual metabolic cages. 24 h later rats were sacrificed, blood collected and nephrectomy and cystectomy performed in order to prepare specimens for histopathological analysis. Circadian diuresis was also assessed, along with a qualitative urine assessment with strip tests and laboratory renal function parameters in plasma and urine: sodium, urea, creatinine and uric acid levels, and circadian elimination of sodium, potassium, urea, creatinine, uric acid and protein. Creatinine clearance, urea clearance and fractionated sodium elimination (FENa) and renal failure index (RFI) were also calculated. An increased diuresis and acidification of urine with reduced circadian elimination of potassium and a significant proteinuria, as well as increased plasma levels of creatinine and urea were found in the group of rats that received a single dose of CP, compared to control animals. Rats treated with IF also demonstrated acidification of urine, reduced circadian potassium elimination, a significant proteinuria and increased plasma creatinine and urea levels, but their diuresis was comparable to that observed in control animals. IF-treated animals were also characterized by reduced urea clearance, FENa and RFI. Histopathological analysis confirmed presence of inflammatory changes in urinary bladders in both groups 1 and 2, and absence of any significant morphological disorders in kidneys. Obtained results suggest a dysfunction of distal tubules and collective tubules developing as a result of administration of a single nephrotoxic dose of IF/CP. FENa and RFI results indicate also a higher nephrotoxic potential of IF administered as a single dose.
dc.affiliationpl
Wydział Lekarski : Zakład Patofizjologii
dc.cm.date
2020-01-07
dc.cm.id
85184
dc.contributor.authorpl
Dobrek, Łukasz - 129181
dc.contributor.authorpl
Skowron, Beata - 161581
dc.contributor.authorpl
Baranowska, Agnieszka - 214008
dc.contributor.authorpl
Ciesielczyk, Katarzyna - 162216
dc.contributor.authorpl
Kopańska, Marta
dc.contributor.authorpl
Thor, Piotr - 133660
dc.date.accessionpl
2019-05-29
dc.date.accessioned
2020-01-17T09:17:57Z
dc.date.available
2020-01-17T09:17:57Z
dc.date.issuedpl
2017
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.additionalpl
Bibliogr. s. 1589
dc.description.numberpl
5
dc.description.physicalpl
1579-1589
dc.description.pointspl
15
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
74
dc.identifier.eissnpl
2353-5288
dc.identifier.issnpl
0001-6837
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/141466
dc.identifier.weblinkpl
http://ptfarm.pl/en/wydawnictwa/czasopisma/acta-poloniae-pharmaceutica/110/-/27067
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne 4.0 Międzynarodowa
dc.rights.licence
CC-BY-NC
dc.rights.uri*
http://creativecommons.org/licenses/by-nc/4.0/legalcode.pl
dc.share.type
otwarte czasopismo
dc.subject.enpl
cyclophosphamide
dc.subject.enpl
ifosfamide
dc.subject.enpl
nephrotoxicity
dc.subject.enpl
rats
dc.subtypepl
Article
dc.titlepl
Nephrotoxicity of a single dose of cyclophosphamide and ifosfamide in rats
dc.title.journalpl
Acta Poloniae Pharmaceutica. Drug Research
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
30
Views per month
Views per city
Karabük
5
Chāliyār
3
Ashburn
2
Boardman
2
Wroclaw
2
Yekaterinburg
2
Al Ma`adi
1
Assiut
1
Az Zubayr
1
Baghdad
1
Downloads
dobrek_et-al_nephrotoxicity_of_a_single_dose_of_cyclophosphamide_and_ifosfamide_in_rats_2017.pdf
46
dobrek_et-al_nephrotoxicity_of_a_single_dose_of_cyclophosphamide_and_ifosfamide_in_rats_2017.odt
4